High-Load AG10 Tablet Formulation for Stable Fast Dissolution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing pharmaceutical formulations of AG10, a potential treatment for TTR amyloid-related diseases, face challenges in achieving stability and consistent pharmacokinetic data, particularly when formulated as high-load tablets, leading to issues such as tablet erosion and reduced dissolution rates.
Innovation Solution
The development of high-load tablet formulations of AG10 using high-grade microcrystalline cellulose and specific pharmaceutical excipients, including fillers, binders, disintegrants, and lubricants, with optional coating, to enhance stability and pharmacokinetic consistency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If high-load tablet formulations of AG10 are developed, then the dosage efficiency is improved, but tablet erosion and reduced dissolution rates occur
Solution Approach 1:
The patent employs a composite tablet formulation containing AG10 (40-85% w/w) combined with specific pharmaceutical excipients including microcrystalline cellulose, croscarmellose sodium, silicon dioxide, and magnesium stearate. This composite material approach allows high drug loading while maintaining tablet structural integrity and dissolution performance through synergistic interactions between components
Solution Approach 2:
The patent systematically optimizes formulation parameters including excipient ratios, particle size distributions, compression forces, and moisture content to achieve stable high-load tablets. By adjusting these parameters, the formulation maintains both high AG10 content and acceptable tablet erosion resistance
2Quantity of substance
If high-load tablet formulations of AG10 are developed, then the dosage efficiency is improved, but dissolution rates are reduced
Solution Approach 1:
The patent incorporates disintegrant excipients (croscarmellose sodium) that pre-establish pathways for rapid drug release upon contact with gastrointestinal fluids. This preliminary structural preparation ensures fast dissolution even at high AG10 loadings by creating immediate channels for water penetration and drug liberation
Solution Approach 2:
The formulation utilizes porous microcrystalline cellulose and silicon dioxide excipients that create a porous matrix structure. This porosity facilitates rapid water penetration and AG10 dissolution while maintaining tablet integrity, resolving the contradiction between high loading and fast dissolution
3Duration of action of stationary object
If extended storage periods are considered, then the stability maintenance is improved, but formulation complexity increases
Solution Approach 1:
The patent employs simple, inexpensive, and widely available pharmaceutical excipients with well-understood stability profiles. These conventional excipients require minimal special handling or storage conditions, achieving extended stability without adding formulation or manufacturing complexity
Solution Approach 2:
The inclusion of silicon dioxide and magnesium stearate creates a protective inert matrix that shields AG10 from environmental degradation factors such as moisture and oxygen. This passive protection mechanism extends storage stability without requiring complex active stabilization systems
Data Source
AI summary
The present disclosure provides high-load tablet formulations of AG10 or a pharmaceutically acceptable salt thereof. In some aspects, provided herein are table formulations of AG10 or a pharmaceutically acceptable salt thereof that include at least 40% or more AG10 by weight and at least one pharmaceutical excipient selected from one or more fillers, one or more binders, one or more disintegrants, and one or more lubricants.